Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular Phenotype, Multigene Assays, and the Locoregional Management of Breast Cancer.

Seminars in radiation oncology - 1 Jan 2016

Braunstein Lior Z, Taghian Alphonse G

Abstract excerpt

Molecular profiling has revealed that breast cancer is not a single disease entity, but rather a class of heterogeneous subtypes, each with its own inherent biology and natural history. As a result, different treatment approaches have been optimized for the various subtypes and, in turn, the ability to identify subtypes has become a critical element in the management of breast cancer. Comprehensive...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Breast Neoplasms
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Testing

Share to Phenotype

Share to Receptors, Estrogen

Source

Identifiers

PMID: 26617205
DOI: 10.1016/j.semradonc.2015.08.002

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular Phenotype, Multigene Assays, and the Locoregional Management of Breast Cancer.PMID 26617205Read ↗

Breast Molecular Profiling and Radiotherapy Considerations.Semantic proximity Read ↗

Molecular and Cellular Heterogeneity in Breast CancerSemantic proximity Read ↗

Molecular Pathology of Breast Tumors: Diagnostic and Actionable Genetic Alterations.Semantic proximity Read ↗

Molecular Pathology of Breast Tumors: Diagnostic and Actionable Genetic Alterations.Semantic proximity Read ↗

Biomarker assessment and molecular testing for prognostication in breast cancerSemantic proximity Read ↗

Multigene classifiers, prognostic factors, and predictors of breast cancer clinical outcome.Semantic proximity Read ↗

Response-based molecular subtyping—emergence of the third generation of breast cancer subtypesSemantic proximity Read ↗

Targeting the Molecular Subtypes of Triple Negative Breast Cancer: Understanding the Diversity to Progress the Field.Semantic proximity Read ↗

Genetic heterogeneity in breast cancer: the road to personalized medicine?Semantic proximity Read ↗

Molecular intrinsic versus clinical subtyping in breast cancer: A comprehensive reviewSemantic proximity Read ↗

Breast cancer biomarkers and molecular medicine.Semantic proximity Read ↗

The Changing Role of Pathology in Breast Cancer Diagnosis and TreatmentSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.